Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

GB Group Ord Shs GBGPF

GB Group plc is a United Kingdom-based company, which provides identity data intelligence products and services helping organizations recognize and verify all elements of an individual's identity at key interactions in their business processes. The Company's segments include location, identity and fraud. The location segment includes address lookup, verification and capture; e-mail validation; phone verification, and data maintenance services. The identity segment includes document verification, data verification and identity investigation services. Its identity verification solutions can be configured to carry out a wide range of functions, including know your customer checks, anti-money laundering checks, age verification checks and liveness detection. The fraud segment includes transaction fraud monitoring, combating origination fraud and in-life fraud investigation services. It provides artificial intelligence powered screening for automatic onboarding or referral of customers.


OTCPK:GBGPF - Post by User

Comment by dionsayson Jan 06, 2018 7:15pm
79 Views
Post# 27298657

RE:RE:RE:RE:RE:Chasing

RE:RE:RE:RE:RE:Chasing
PROtrading wrote: Read the press release FROM Aurora on November 14th 2017.  The offer is for $24 in ACB shares!  The wording of the press release is confusing because it's talks about $24 as if it's cash but the detail spell it out with some confusing market gaming from Aurora and Canaclown.

2017-11-14 19:37 ACB Aurora Cannabis Inc 6.41 News Release Aurora Cannabis makes $24-a-share offer for CanniMed

"Pursuant to the proposal, CanniMed shareholders will be entitled to receive a maximum of $24 per CanniMed share or 4.52586207 Aurora shares, based on the 20-day volume-weighted average price of Aurora. Based on the closing price of Aurora shares on Nov. 14, 2017, this translates to 3.74415 Aurora shares for each CanniMed share. Based on the closing prices of Aurora and CanniMed on Nov. 14, 2017, this represents a premium of approximately 56.9-per-cent premium over the closing price of CanniMed shares on Nov. 14, 2017, and a 74.7-per-cent premium over the 20-day volume-weighted average price for the period ended Nov. 14, 2017. Upon completion of the transactions contemplated by the proposal, based on the closing prices of Nov. 14, 2017, CanniMed's shareholders will hold approximately 16 per cent of the issued and outstanding shares of Aurora."

Don't blame CMED's actions here guys. There's friendly takeovers where management go into a quiet period and hash things out to then announce in public and there's HOSTILE takeover where the acquirer uses the public to negociate and "market game".

VENMan wrote: thorgb1, you're right there was NEVER any formal offer of 4.5 shares of ACB. That's why CMED's Management team should have taken the ACB offer and many phone calls made by ACB more seriously and worked on a little better deal rather than outright reject the offer. Don't play with my words and say I'm being dishonest because you know what I'm trying to get at. Look at what you have now with HIP and CMED's deal. The dilution after the CMED / HIP deal was a concern to many CMED shareholders but many could have accepted including CMED's Management upwords of 35 million shares outstanding as the deal stood. Today however HIP trades at pretty much the same Market Cap as CMED so you tell me how happy are you going to be with upwards of 100 million shares outstanding or way more in order to get this deal with HIP done because NO HIP shareholder in HIS or HER right mind is going to accept .033 a CMED share any longer. So now you either offer HIP a better deal which costs you bigtime dilution or take 1 ACB share when ACB trades at $24 for 20 trading days. And don't think it won't happen in this Market when HIP with little to nothing is trading at $1.51, good God ACB at  $24 would be a better deal than buying HIP with a $600 million Market Cap before you offer them a premium and you know it. Offer HIP nothing more and they will not accept the current offer and CMED is in the hands of ACB. Kind Regards and ALL IMO!!




There is two options that CMED shareholders can choose as per the news release
CanniMed shareholders will be entitled to receive a maximum of $24 per CanniMed share or 4.52586207 Aurora shares

1) A maximum  of $24 per dollars per CMED share
or
2) 4.5 ACB shares
which would you choose?



<< Previous
Bullboard Posts
Next >>